Omico: Using Genomics to Accelerate Access to Next Generation Cancer Treatments

The MTPConnect Podcast

Conteúdo fornecido por MTPConnect. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por MTPConnect ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

2M ago 39:38

MP3•Home de episódios

Omico is leading Australia’s largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international trials to Australia.

Professor David Thomas, renowned for his groundbreaking work in precision oncology, is the founder and Chief Science and Strategy Officer of Omico - the Australian Genomic Cancer Medicine Centre.

In this episode, host Caroline Duell speaks with Professor Thomas to find out more about his mission to open up new treatment options for all cancer patients using genomics, the impact of pan tumour therapies on our healthcare system, and why we need to change the way we look at cancer care and cure right now before more people die unnecessarily.

184 episódios

#Science #Tech #Fitness #Medicine #MTPConnect #Health and Well-Being #Medtech #Pharma #Industries